Oxymetazoline Hcl
NDC Package 73414-002-17
Package Information
Oxymetazoline Hcl is uses Temporarily relieves nasal congestion due to:common coldhay feverupper respiratory allergiesshrinks swollen nasal membrances so you can breathe more freely. Marketed by Seaway Pharma Inc., this product is identified by NDC 73414-002 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1000990 - oxymetazoline HCl 0.05 % Nasal Spray
- RxCUI: 1000990 - oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray
- RxCUI: 1000990 - oxymetazoline hydrochloride 0.05 % Nasal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 73414 - Seaway Pharma Inc.
- 73414-002 - Oxymetazoline Hcl
- 73414-002-17 - 1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
- 73414-002 - Oxymetazoline Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (73414-002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 73414-002-17 identifies a specific commercial package of 1 bottle in 1 carton / 15 ml in 1 bottle of Oxymetazoline Hcl, labeled by Seaway Pharma Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Seaway Pharma Inc. on January 01, 2020. The current certification is valid through December 31, 2021.
How is this Seaway Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 73414000217. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.